Patrick F. Smith
President, Certara Drug Development SolutionsDr. Patrick F. Smith is President, Certara Drug Development Solutions, where he leads a global team of drug development scientists that creates value for clients across the entire life cycle and ultimately accelerates patient access to medicines. Patrick은 20년간의 신약 개발 경력을 통해 전염병, 종양학 및 염증에 대한 심도 있는 전문 지식과 새로운 초기 개발 프로그램 설계 및 중요한 개발 문제를 해결하기 위한 모델링 및 시뮬레이션 적용을 통해 신약 개발의 모든 단계에서 일했습니다.
Previously, Patrick was co-founder of d3 Medicine (acquired by Certara in 2016), helping to build a healthcare company that specialized in providing strategic support for complex development programs. Prior to d3 Medicine, Patrick was U.S. Clinical Pharmacology Lead at Roche for more than 5 years, where he worked in various roles of increasing responsibility in clinical pharmacology and translational medicine. He has served as an Associate Professor at the University at Buffalo School of Pharmacy and Roswell Park Cancer Institute in Buffalo, NY. Patrick has published more than 125 peer-reviewed articles in journals, including the New England Journal of Medicine and Lancet. He holds a PharmD from the University of California, San Francisco and completed his clinical residency at Duke University Medical Center.
